Dr Patel on the Efficacy of Anitocabtagene Autoleucel in R/R Multiple Myeloma | OncLive
Dr Patel on the Efficacy of Anitocabtagene Autoleucel in R/R …
3 months ago
onclive.com
Le NICE recommande l'Aucatzyl® (Obecabtagene Autoleucel) comme option thérapeutique pour les adultes atteints de leucémie aiguë lymphoblastique à précurseurs B en rechute ou réfractaire
Le NICE recommande l'Aucatzyl® (Obecabtagene Autoleucel) comm…
3 months ago
zonebourse.com
Dr. Jacobson on FDA Approval of Brexucabtagene Autoleucel in Relapsed/Refractory MCL | OncLive
Dr. Jacobson on FDA Approval of Brexucabtagene Autoleucel in Rel…
Oct 26, 2020
onclive.com
Is There a Potential Role for Rapcabtagene Autoleucel in R/R LBCL?
Is There a Potential Role for Rapcabtagene Autoleucel in R/R L…
Feb 7, 2023
onclive.com
Influences on Treatment Response and Survival in Recipients of Brexucabtagene Autoleucel Therapy | OncLive
14:59
Influences on Treatment Response and Survival in Recipients of Brex…
Feb 9, 2024
onclive.com
Dr Shah on Zamtocabtagene Autoleucel’s Favorable Safety Profile in R/R DLBCL | OncLive
Dr Shah on Zamtocabtagene Autoleucel’s Favorable Safety Pro…
2 weeks ago
onclive.com
Dr Riedell on Efficacy and Safety of Rapcabtagene Autoleucel in R/R DLBCL | OncLive
Dr Riedell on Efficacy and Safety of Rapcabtagene Autoleucel in R/R D…
Jan 3, 2025
onclive.com
Dr Ikegawa on An Analysis of Rapidly Manufactured Durcabtage…
Oct 5, 2023
onclive.com
15:06
Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory A…
Dec 20, 2023
onclive.com
Adaptimmune Therapeutics plc: Adaptimmune Receives U.S. FDA …
Feb 8, 2024
finanznachrichten.de
1:02
Budget 2026: 17 Cancer Drugs Now TAX-FREE in India!
303 views1 month ago
YouTubeHealth Wealth
2:33
Doris Hansen, MD: Real-world non-ICANS neurologic events with cilt…
10 views3 months ago
YouTubeMoffitt Cancer Center
9:04
Anitocabtagene Autoleucel in RRMM: Efficacy, Safety, and Impr…
14 views1 month ago
YouTubeOncology Data Advisor
1:42
The safety and efficacy of var-cel (ARI-0001) in patients with R/R ma…
4 views4 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:44
Results of the Phase II CART19-BE-02 trial of var-cel (ARI-0001) in pati…
16 views2 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:02
Anitocabtagene autoleucel achieves deep and durable responses in rel…
2 months ago
Vimeoecancer
1:11
Redefining second-line therapy in myeloma with CAR T-cell therapy
1 views3 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:58
Redefining high-risk myeloma in the context of upfront quadruplet ther…
3 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:36
Pearl van Heteren, MD, on the DALY 2-EU trial in R/R DLBCL
19 views2 months ago
YouTubeThe Society of Hematologic Oncology
4:49
Dr. Parekh on how earlier lines of cilta-cel are linked to better immu…
1 views2 months ago
YouTubeThe Society of Hematologic Oncology
5:41
Mechanism of Action of FUCASO – A Breakthrough CAR-T Therapy fo…
2 views1 week ago
YouTubeCARTMASTER
0:21
Dr. Parekh on his #ash25 abstract on the link between the earlier us…
3 views1 month ago
YouTubeThe Society of Hematologic Oncology
2:56
2026 Budget: 17 Cancer Medicines Now Cheaper | Dr Chandrakanth M…
233 views1 month ago
YouTubeM V Chandrakanth
2:05
Dr Disha - advanced physio care-Knee Specialist & Aqua Physio | B…
3.2K views1 month ago
Instagramdr.dishadedhia
2:01
CAR-T updates in myeloma
320 viewsJun 10, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
7:26
EVOLVE: Orva-cel in RRMM
162 viewsMay 30, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:59
Key updates from the IMW 2021 meeting
156 viewsSep 14, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:10
KarMMa: idecabtagene vicleucel QoL
194 viewsJun 18, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:00
ALL and CLL updates at ASCO 2021
255 viewsJun 14, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:43
CAR-NK and CAR-T for MCL
308 viewsJun 9, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder